Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia
Open Access
- 18 July 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (7), e0200504
- https://doi.org/10.1371/journal.pone.0200504
Abstract
There is only limited information on mortality over extended periods in hospitalized patients with pneumococcal community-acquired pneumonia (CAP). We aimed to evaluate the 30-day mortality and whether is changed over a 20-year period among immunocompetent adults hospitalized with pneumococcal CAP. We conducted a retrospective observational study of data that were prospectively collected at the Hospital Clinic of Barcelona of all adult patients hospitalized with diagnosis of pneumococcal CAP over a 20-year period. To aid analysis, results were divided into four periods of 5 years each (1997–2001, 2002–2006, 2007–2011, 2012–2016). The primary outcome was 30-day mortality, but secondary outcomes included intensive care unit (ICU) admission, lengths of hospital and ICU-stays, ICU-mortality, and need of mechanical ventilation. From a cohort of 6,403 patients with CAP, we analyzed the data for 1,120 (17%) adults with a diagnosis of pneumococcal CAP. Over time, we observed decreases in the rates of alcohol consumption, smoking, influenza vaccination, and older patients (age ≥65 years), but increases in admissions to ICU and the need for non-invasive mechanical ventilation. The overall 30-day mortality rate was 8% (95% confidence interval, 6%–9%; 84 of 1,120 patients) and did not change significantly between periods (p = 0.33). Although, we observed a decrease in ICU-mortality comparing the first period (26%) to the second one (10%), statistical differences disappeared with adjustment (p0.38). Over time, 30-day mortality of hospitalized pneumococcal CAP did not change significantly. Nor did it change in the propensity-adjusted multivariable analysis. Since mortality in pneumococcal pneumonia has remained unaltered for many years despite the availability of antimicrobial agents with proven in vitro activity, other non-antibiotic strategies should be investigated.Keywords
This publication has 42 references indexed in Scilit:
- Improvement in process of care and outcome in patients requiring intensive care unit admission for community acquired pneumoniaBMC Infectious Diseases, 2013
- Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter studyCritical Care, 2012
- Microbial aetiology of community-acquired pneumonia and its relation to severityThorax, 2011
- Trends in Mortality and Medical Spending in Patients Hospitalized for Community-Acquired PneumoniaMedical Care, 2010
- Multiple imputation for missing data in epidemiological and clinical research: potential and pitfallsBMJ, 2009
- Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate VaccineClinical Infectious Diseases, 2008
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockIntensive Care Medicine, 2004
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983